|
VASH2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.658400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.684400E-02 |
| Normal-vs-Stage2 |
6.372400E-02 |
| Normal-vs-Stage3 |
3.617900E-02 |
| Normal-vs-Stage4 |
2.274600E-01 |
| Stage1-vs-Stage2 |
3.622000E-01 |
| Stage1-vs-Stage3 |
3.437400E-01 |
| Stage1-vs-Stage4 |
9.617800E-01 |
| Stage2-vs-Stage3 |
9.493000E-01 |
| Stage2-vs-Stage4 |
6.264800E-01 |
| Stage3-vs-Stage4 |
6.383000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.240900E-03 |
| Normal-vs-AfricanAmerican |
2.144800E-01 |
| Normal-vs-Asian |
4.565600E-01 |
| Caucasian-vs-AfricanAmerican |
2.536100E-02 |
| Caucasian-vs-Asian |
3.135400E-01 |
| AfricanAmerican-vs-Asian |
8.918200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.540040E-02 |
| Normal-vs-Female |
9.101000E-03 |
| Male-vs-Female |
6.324000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.122300E-02 |
| Normal-vs-Extreme_Weight |
1.585400E-01 |
| Normal-vs-Obese |
3.692400E-02 |
| Normal-vs-Extreme_Obese |
8.042100E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.877600E-01 |
| Normal_Weight-vs-Obese |
8.587800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.264200E-01 |
| Extreme_Weight-vs-Obese |
3.990000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.351400E-01 |
| Obese-vs-Extreme_Obese |
8.111600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.511600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.403600E-03 |
| Normal-vs-Age(61-80Yrs) |
3.275900E-02 |
| Normal-vs-Age(81-100Yrs) |
8.515000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.065600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.488000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.045800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.726400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.556100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.938300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.664160E-02 |
| Normal-VS-Type2 PRCC |
7.411600E-02 |
| Normal-VS-KIRP CIMP |
3.674200E-01 |
| Normal-VS-Unclassified PRCC |
2.856100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.787600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.747600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.090400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.696400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.236800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.374200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.257500E-02 |
| Normal-vs-N1 |
5.987900E-02 |
| Normal-vs-N2 |
4.341200E-01 |
| N0-vs-N1 |
1.500170E-01 |
| N0-vs-N2 |
6.086600E-01 |
| N1-vs-N2 |
7.973800E-01 |
|
|
